Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05986916 · ClinicalTrials.gov registry record

Accurate Point of Care Liver Disease Diagnostics

A clinical trial of NAFLD and Nonalcoholic Fatty Liver, sponsored by University of California, San Diego.

Active
Registry status
50
Enrollment target
1
Study location

NCT05986916 is a study of NAFLD and Nonalcoholic Fatty Liver that is active but no longer recruiting, run by University of California, San Diego. The registered enrollment target is 50 participants, below the 163-participant average among 26 other NAFLD trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05986916, a study of NAFLD and Nonalcoholic Fatty Liver, is active but no longer recruiting, sponsored by University of California, San Diego.

ACTIVE NOT RECRUITING
Registry status
50 participants
Enrollment target
1
Study location

Study Summary

This research study is being conducted to find out more about techniques to non-invasively evaluate liver disease. The investigators are testing a new technology to evaluate the liver (LiverScope®), and they will compare it to other methods to evaluate the liver, including advanced conventional liver MR and liver FibroScan® ultrasound exams. MR exams and FibroScan® ultrasound exams are common exams used to monitor NAFLD. Conventional MR scanners use magnetic fields and radio waves to make pictures of the liver. LiverScope® is a small, portable MR-based device that uses similar, but simplified technology, and can be used on top of an exam table in an outpatient setting. LiverScope® currently is not approved for clinical use. In this study the investigators will learn how LiverScope® measurements of the liver compare to MR. Study participants will be asked to complete a one-time visit which includes: * LiverScope exam * MR exam * FibroScan exam (optional) * Blood draw * Completion of study questionnaires

Conditions Studied

NAFLD Nonalcoholic Fatty Liver

Interventions

  • OTHER Blood draw
  • DIAGNOSTIC_TEST MR exam
  • DIAGNOSTIC_TEST Liverscope® exam
  • DIAGNOSTIC_TEST FibroScan® exam (optional)
  • OTHER Body measurements

Study Locations (1)

California

  • University of California San Diego - La Jolla

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2023-08-03
Est. Completion 2025-11

Sponsor

University of California, San Diego

775 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05986916

The ClinicalTrials.gov registry entry for NCT05986916 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 163-participant average among 26 other NAFLD trials with a reported enrollment target (69% lower). The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with NAFLD appearing as the primary indexed condition, and to 5 interventions - of which Blood draw is the first listed.

NCT05986916 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05986916 about?

NCT05986916 is a clinical study titled "Accurate Point of Care Liver Disease Diagnostics". This research study is being conducted to find out more about techniques to non-invasively evaluate liver disease. The investigators are testing a new technology to evaluate the liver (LiverScope®), and they will compare it to other methods to evaluate the liver, including advanced conventional live...

What is the current status of trial NCT05986916?

This trial is currently active not recruiting. The enrollment target is 50 participants. The study started on 2023-08-03. Estimated completion is 2025-11.

What conditions does trial NCT05986916 study?

This clinical trial studies the following conditions: NAFLD, Nonalcoholic Fatty Liver.

What interventions are being tested in trial NCT05986916?

The interventions under investigation include: Blood draw (OTHER), MR exam (DIAGNOSTIC_TEST), Liverscope® exam (DIAGNOSTIC_TEST), FibroScan® exam (optional) (DIAGNOSTIC_TEST), Body measurements (OTHER).

Who is sponsoring clinical trial NCT05986916?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05986916 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for NAFLD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

NAFLD

All registered trials for this condition

Nonalcoholic Fatty Liver

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.